Other

Current maturities of long-term debt

This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026

How to read this metric

An increase indicates higher short-term cash outflows required to service lease debt.

Detailed definition

This represents the portion of finance lease obligations that is due within the next twelve months. It is a key indicato...

Peer comparison

Comparable to other companies with significant finance lease obligations.

Metric ID: other_finance_lease_liability_current

Historical Data

9 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q4 '25Q1 '26
Value$718.40M$719.00M$719.70M$0.00$0.00$0.00$0.00$0.00$720.00M
QoQ Change+0.1%+0.1%-100.0%
YoY Change-100.0%-100.0%-100.0%
Range$0.00$720.00M
CAGR+0.1%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Regeneron Pharmaceuticals's current maturities of long-term debt?
Regeneron Pharmaceuticals (REGN) reported current maturities of long-term debt of $720.00M in Q1 2026.
What does current maturities of long-term debt mean?
The amount of finance lease payments due within one year.